Botterel, F.
Publications
P286
J. Mycol. Med. 2024, 34, 101490.
Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).
P257
Med. Mycol. 2022, 60, myac021.
GMC study group. Contribution of the anaerobic blood culture vial for the recovery of Candida glabrata: A retrospective multicentric study.
P243
Lancet Respir. Med. 2022, 10, 180-190.
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
P226
J. Mycol. Med. 2020, 30, 100970.
Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
doi: 10.1016/j.mycmed.2020.100970
P190
J. Cyst. Fibros. 2019, 18, 212-220.
Prevalence, geographic risk factor, and development of standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study "MFIP".
doi: 10.1016/j.jcf.2018.10.001
P147
Antimicrob. Agents Chemother. 2016, 60, 5088-5091.
Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
doi: 10.1128/AAC.00630-16
Autres publications scientifiques
PS06
Parasite. 2022, 29.
Selecting a multiplex PCR panel for accurate molecular diagnosis of intestinal protists: a comparative study of Allplex® (Seegene®), G-DiaParaTrio (Diagenode®), and RIDA®GENE (R-Biopharm®) assays and microscopic examination.